VivoSeq
Other

Asphyxia

7

Pipeline Programs↗

3

Active Trials↗

5

Companies Involved↗

Asphyxia is an early-stage landscape with 7 programs across 5 companies. The most active players are Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Viatris Specialty LLC, Neurim Pharmaceuticals Ltd.. 2 programs are in Phase 3.

Intelligence

Pipeline Metrics

Competitive Density

34/100

Pipeline Velocity

6/100

Mech. Concentration

25/100

Completion Rate

91/100

Attrition Rate

7/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. logo

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

1 program

Phase 1V

Viatris Specialty LLC

1 program

Phase 1N

Neurim Pharmaceuticals Ltd.

1 program

Phase 2V

Validus Pharmaceuticals

1 program

PreclinicalF

Fresenius Kabi Oncology Ltd.

1 program

Preclinical

Pipeline

Programs by Phase

Analysis

Trial Status

14

clinical trials

Completed10 · 71%
Active, not recruiting1 · 7%
Not yet recruiting1 · 7%
Terminated1 · 7%
Recruiting1 · 7%

Clinical Trials

Trial Activity

14 trials

Optimization of Routine Obstetric and Neonatal Care in the Management of Severe Perinatal Asphyxia in Term or Near-term Newborns: Analysis of Sub-optimal Care
Recruiting·AAssistance Publique - Hôpitaux de Paris·N/A·NCT06322732·336 enrolled
Finding Solutions to Thrive After Birth Asphyxia in Africa
Active, not recruiting·—·Phase 1·NCT05275725·18 enrolled
Nephroprotection Following Perinatal Asphyxia: Randomized Controlled Trial
Not yet recruiting·—·N/A·NCT07088328·30 enrolled
Neuroprotective Efficacy of Postnatal Magnesium Sulphate in Term Infants With Birth Asphyxia
Completed·UUniversity of Health Sciences Lahore·N/A·NCT05707962·178 enrolled
Neuroprotective Role of Erythropoietin in Perinatal Asphyxia
Completed·SSheri Kashmir Institute of Medical Sciences·Phase 2/3·NCT02002039·100 enrolled
First-day High Dose Vitamin C, E in Severe Birth Asphyxia
Completed·SSir Takhtasinhji General Hospital·Phase 4·NCT01743742·95 enrolled
Efficacy and Safety of Summers Non-Pesticide Lice Asphyxiator (L.A.)for the Treatment of Head Lice
Completed·SSummers Laboratories·Phase 3·NCT00301340·200 enrolled
Neonatal Erythropoietin in Asphyxiated Term Newborns
Completed·UUniversity of California, San Francisco·Phase 1·NCT00719407·24 enrolled
Efficacy and Safety of Summers Non-Pesticide Lice Asphyxiator (L.A.)for the Treatment of Head Lice.
Completed·SSummers Laboratories·Phase 3·NCT00301327·120 enrolled
Magnesium Sulphate in Perinatal Asphyxia
Completed·SSheri Kashmir Institute of Medical Sciences·Phase 3·NCT00553072·40 enrolled
Enhancing Neonatal Sucking Reflex: A Study on the Efficacy of Magnesium Sulphate in Severe Birth Asphyxia
Completed·RRESnTEC, Institute of Research·N/A·NCT06468475·80 enrolled
Efficacy and Safety of Summers Non-Pesticide Lice Asphyxiator (L.A.)for the Treatment of Head Lice
Completed·SSummers Laboratories·Phase 3·NCT00479310·120 enrolled
Melatonin for Neuroprotection Following Perinatal Asphyxia
Completed·TTanta University·Phase 1/2·NCT02071160·45 enrolled
A Study of 2-Iminobiotin in Neonates With Perinatal Asphyxia
Terminated·—·Phase 2·NCT01626924·6 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)